Prostate-apoptosis-response-gene-4 increases sensitivity to TRAIL-induced apoptosis.

[1]  D. Lawrence,et al.  Selective Knockdown of the Long Variant of Cellular FLICE Inhibitory Protein Augments Death Receptor-mediated Caspase-8 Activation and Apoptosis* , 2005, Journal of Biological Chemistry.

[2]  Dan Xu,et al.  Specific Cleavage of Mcl-1 by Caspase-3 in Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis in Jurkat Leukemia T Cells* , 2005, Journal of Biological Chemistry.

[3]  K. Schulze-Osthoff,et al.  Caspase-8 Can Be Activated by Interchain Proteolysis without Receptor-triggered Dimerization during Drug-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[4]  C. Belka,et al.  Type I and type II reactions in TRAIL-induced apoptosis – results from dose–response studies , 2005, Oncogene.

[5]  P. Secchiero,et al.  TNF-related apoptosis-inducing ligand (TRAIL): a potential candidate for combined treatment of hematological malignancies. , 2004, Current pharmaceutical design.

[6]  S. Boehrer,et al.  Prostate apoptosis response gene-4 sensitizes neoplastic lymphocytes to CD95-induced apoptosis , 2004, Annals of Hematology.

[7]  A. Groyer,et al.  Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells , 2004, Oncogene.

[8]  J. Tschopp,et al.  N-Terminal Fragment of c-FLIP(L) Processed by Caspase 8 Specifically Interacts with TRAF2 and Induces Activation of the NF-κB Signaling Pathway , 2004, Molecular and Cellular Biology.

[9]  Wafik S El-Deiry,et al.  TRAIL and apoptosis induction by TNF-family death receptors , 2003, Oncogene.

[10]  O. Micheau.  Cellular FLICE-inhibitory protein: an attractive therapeutic target? , 2003, Expert opinion on therapeutic targets.

[11]  C. Belka,et al.  Molecular requirements for the combined effects of TRAIL and ionising radiation. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  A. Ashkenazi,et al.  Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. , 2003, Cytokine & growth factor reviews.

[13]  Sandip K. Mishra,et al.  Par-4 Transcriptionally Regulates Bcl-2 through a WT1-binding Site on the bcl-2 Promoter* , 2003, Journal of Biological Chemistry.

[14]  M. Degli Esposti,et al.  The roles of Bid , 2002, Apoptosis.

[15]  Xiaolu Yang,et al.  c‐FLIPL is a dual function regulator for caspase‐8 activation and CD95‐mediated apoptosis , 2002, The EMBO journal.

[16]  N. Mitsiades,et al.  Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells. , 2002, Blood.

[17]  V. Rangnekar,et al.  In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation. , 2002, Cancer research.

[18]  Min Chen,et al.  Initiator caspases in apoptosis signaling pathways , 2002, Apoptosis.

[19]  H. Shu,et al.  The short splice form of Casper/c‐FLIP is a major cellular inhibitor of TRAIL‐induced apoptosis , 2002, FEBS letters.

[20]  J. Blenis,et al.  Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8* , 2001, The Journal of Biological Chemistry.

[21]  P. Krammer,et al.  FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis , 2001, Molecular and Cellular Biology.

[22]  H. Chun,et al.  Caspase-10 is an initiator caspase in death receptor signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Burns,et al.  Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. , 2001, The Journal of biological chemistry.

[24]  R. K Srivastava,et al.  Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways , 2001, Oncogene.

[25]  R. Khosravi‐Far,et al.  The Complexity of TNF‐Related Apoptosis‐Inducing Ligand , 2000, Annals of the New York Academy of Sciences.

[26]  D. Goeddel,et al.  Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. , 2000, Immunity.

[27]  J. Blenis,et al.  FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. , 2000, Immunity.

[28]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[29]  J. Tschopp,et al.  TRAIL receptor-2 signals apoptosis through FADD and caspase-8 , 2000, Nature Cell Biology.

[30]  S. Kawanishi,et al.  TRAIL causes cleavage of bid by caspase-8 and loss of mitochondrial membrane potential resulting in apoptosis in BJAB cells. , 1999, Biochemical and biophysical research communications.

[31]  D. Lawrence,et al.  Safety and antitumor activity of recombinant soluble Apo2 ligand. , 1999, The Journal of clinical investigation.

[32]  C. Rauch,et al.  Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.

[33]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[34]  J C Reed,et al.  IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases , 1998, The EMBO journal.

[35]  P. Golstein.  Cell death: TRAIL and its receptors. , 1997, Current biology : CB.

[36]  S. Srinivasula,et al.  Identification and Molecular Cloning of Two Novel Receptors for the Cytotoxic Ligand TRAIL* , 1997, The Journal of Biological Chemistry.

[37]  Henning Walczak,et al.  TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL , 1997, The EMBO journal.

[38]  Y. Goltsev,et al.  CASH, a Novel Caspase Homologue with Death Effector Domains* , 1997, The Journal of Biological Chemistry.

[39]  W I Wood,et al.  Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.

[40]  S. Srinivasula,et al.  FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[41]  M. Mattson,et al.  Expression and function of the leucine zipper protein Par-4 in apoptosis , 1997, Molecular and cellular biology.

[42]  D. Goeddel,et al.  Casper is a FADD- and caspase-related inducer of apoptosis. , 1997, Immunity.

[43]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[44]  J. Bertin,et al.  Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Marsters,et al.  Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.

[46]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[47]  S. Humphreys,et al.  Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[48]  V. Rangnekar,et al.  Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemia. , 2001, The hematology journal : the official journal of the European Haematology Association.

[49]  S. Korsmeyer,et al.  Death and survival signals determine active/inactive conformations of pro-apoptotic BAX, BAD, and BID molecules. , 1999, Cold Spring Harbor symposia on quantitative biology.

[50]  N. Williams,et al.  Immunohistochemical Analysis of the Proapoptotic Protein Par-4 in Normal Rat Tissues1 Strange, And , 1997 .